This Bioengineered Wound Care Report Is Now Available

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3bbf17/bioengineered_woun) has announced the addition of the "Bioengineered Wound Care" report to their offering.

A comprehensive assessment of the bioengineered wound care technologies and products for advanced wound management, this report provides a detailed analysis of twenty-two next-generation wound care products, including tissue-engineered skin substitutes, synthetic and harvested regeneration matrices, autologous grafts and biologically active cellular therapies. Management of chronic wounds and ulcers remains one of the most costly unsolved healthcare challenges. The report profiles companies active in bioengineered wound care therapeutics, and evaluates technology and business risk factors and market issues. This is a market that is experiencing unabated growth, as the aging of populations in developed countries leads to increasing caseloads of chronic wounds due to disease and immobility. With conditions such as diabetes, a major cause of skin ulcers, forecast to grow worldwide during the next fifteen years, demand for advanced wound care products and therapies will flourish. The report provides an easy-to-understand assessment of bioengineered wound care and the impact it will have on the advanced wound management segment of the healthcare industry.

Bioengineered Wound Care: Products, Players and Prospects is a comprehensive evaluation and analysis of the markets, products and participants in the technology-driven advanced wound management segment of the Healthcare sector.

New Tools and Treatments for Wound Management: The introduction of new technologies and products for the treatment of acute and chronic wounds is providing caregivers with a set of powerful options that will have a profound effect on the field of wound management. These new treatment tools, which mimic the body's natural physiology and/or regenerative pathways, include tissue-engineered skin substitutes, regeneration matrices, and biologically active cellular therapies. First emerging as a viable treatment for refractory wounds in 1999, a number of products are currently available for certain indications, while others are in pre-clinical or clinical development.

These bioengineered products are competing in a worldwide market worth billions, and in which improvements in quality-of-life and treatment outcomes continue to be top healthcare industry initiatives. While pricing for these new-generation products represents a significant premium relative to existing wound care products, recent studies indicate their ability to promote healing in otherwise refractory wounds places them on a competitive plane in terms of total cost of treatment. As further data on patient outcomes becomes available, we expect the number of indications as well as third party payer acceptance of next-generation wound care products to increase, driving growth to significant levels by the middle of the decade.

Feature Summary

-Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for treating acute and chronic wounds

-Assesses business risk factors and market issues

-Provides detailed analysis of twenty-two bioengineered wound care products

-Forecasts technology and product developments, and projects probable market impact through 2009

-Profiles bioengineered wound care companies, their product development activity, and strategies

-Evaluates the impact of economic, technology, and regulatory factors

Key Topics Covered:

Executive Summary

Advanced Wound Care Market Dynamics

Engineered Wound Care Product Analysis

Market Sector Assessments & Opportunities

Business Sector Strategies and Risks

Market Factors

Companies Mentioned:

- Advanced Biohealing

- Bertek/Mylan

- CellTran Ltd.

- Collagen Matrix, Inc.

- Cook Biotech

- Genzyme Biosurgery

- Healthpoint/DFB

- Integra LifeSciences

- Johnson & Johnson

- Lifecell

- Organogenesis

- Ortech

- Stratatech

- TEI Biosciences

For more information visit http://www.researchandmarkets.com/research/3bbf17/bioengineered_woun.